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Abstract
Background: It is a priority to achieve an adequate nutritional status of iodine during pregnancy since iodine
deficiency in this population may have repercussions on the mother during both gestation and post partum as
well as on the foetus, the neonate and the child at different ages. According to the WHO, iodine deficiency is the
most frequent cause of mental retardation and irrreversible cerebral lesions around the world. However, few
studies have been published on the nutritional status of iodine in the pregnant population within the Primary Care
setting, a health care level which plays an essential role in the education and control of pregnant women.
Therefore, the aim of the present study is: 1.- To know the hygiene-dietetic habits related to the intake of foods
rich in iodine and smoking during pregnancy. 2.- To determine the prevalence of iodine deficiency and the factors
associated with its appearance during pregnancy.
Methods/design: We will perform a cluster randomised, controlled, multicentre trial. Randomisation unit: Primary
Care Team. Study population: 898 pregnant women over the age of 17 years attending consultation to a midwife
during the first trimester of pregnancy in the participating primary care centres. Outcome measures: consumption
of iodine-rich foods and iodine deficiency. Points of assessment: each trimester of the gestation. Intervention:
group education during the first trimester of gestation on healthy hygiene-dietetic habits and the importance of
an adequate iodine nutritional status. Statistical analysis: descriptive analysis of all variables will be performed as
well as multilevel logistic regression. All analyses will be done carried out on an intention to treat basis and will be
fitted for potential confounding factors and variables of clinical importance.
Discussion: Evidence of generalised iodine deficiency during pregnancy could lead to the promotion of
interventions of prevention such as how to improve and intensify health care educational programmes for
pregnant women.
Trial Registration: ClinicalTrials.gov: NCT01301768
Background
Iodine is a fundamental micronutrient for the organism
which should be regularly administered through foods.
Its function is essential for the synthesis of thyroid hor-
mones which in turn act on the different organs and
systems of the organism especially in the development
of the central nervous system (CNS) from the earliest
stages of embryonic and foetal development.
The ingestion of iodine depends on the type of foods
consumed, their origin and preparation. Depending on
the geographical area, products from the earth may have
scarce iodine content. However, foods of marine origin
are rich in this micronutrient [1]. In addition, it should
be taken into account that foods lose iodine during their
preparation: 20% is lost on frying, 23% on baking and
58% on boiling [2]. Some studies have shown that the
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iodine content of cows’ milk differs according to what
the animals are fed [3].
All these factors and alimentary habits make it diffi-
cult for the daily iodine requirements of the population
to be covered through diet. Moreover, iodine is not
stored in the body and must therefore be continually
replenished. In normal conditions there is equilibrium
between iodine intake and urinary elimination, and
determination of iodine in urine (ioduria) constitutes a
good indicator of iodine intake [4], with assessment of
ioduria in a casual urine sample providing adequate
information on the nutritional status of iodine [5].
During pregnancy there is an increase in thyroid hor-
mone requirements due to the physiological modifica-
tions produced in response to the metabolic demands of
pregnancy. This increase can only be achieved by a pro-
portional increase in hormone production which directly
depends on the availability of iodine in the diet. More-
over, gestation produces a physiological increase in the
elimination of iodine in the urine because of a rise in glo-
merular filtration. In cases with an underlying deficit in
iodine these modifications of pregnancy may not be com-
pensated leading to failure of the mechanisms of adapta-
tion. It is therefore very important to increase iodine
intake from the beginning of gestation and even before-
hand if possible, similar to the recommendations of sup-
plementation of folic acid. The thyroid hormones
available for embryonic and foetal tissue during the first
trimester of gestation depend exclusively on maternal
hormones and thus, a deficit in maternal iodine can have
negative repercussions on prenatal development [6].
According to the World Health Organization (WHO)
together with the United Nations International Chil-
dren’s Emergency Fund (UNICEF) and the International
Council for Control of Iodine Deficiency Disorders
(ICCIDD) the iodine needs of pregnant women have
been established as 200 μg/L/day [4]. The ICCIDD has
recently raised this recommendation to 250-300 μg/L/
day. Maternal iodine intake may be calculated by the
determination of ioduria (level of iodine in urine) taking
into account that the factor of dilution in urine is
greater in pregnant women than in the remaining popu-
lation. The value of ioduria indicating optimum iodine
intake during gestation should be between 150 and
230 μg/L [7]. Studies carried out in different European
countries such as France, England, Germany, Switzer-
land, Ireland and Hungary have demonstrated the highly
variable values of iodine deficiency (values less than
150 μg/L) in pregnant women, from 3.5% in England to
57.1% in Hungary [8-13].
Another aspect to consider within hygienic-dietetic
habits of pregnant women is smoking and the repercus-
sion this may have on maternal thyroid function. Smok-
ing is considered a goitrogenic substance since it
inhibits the absorption of iodine during both gestation
and the period of lactation [14]. Smoking during gesta-
tion is associated with changes in the levels of thyroid
function in both the mother and the foetus. The con-
centration of Thyroid-stimulating Hormone (TSH) in
the mother (in the first and third trimester of gestation)
and in the blood of the umbilical cord are lower and the
T3 levels are higher which may trigger adverse effects
for both [15,16]. It has also been reported that smoking
during the period of lactation increases the risk of
iodine deficiency which may lead to brain damage in the
lactating child [14].
Iodine deficiency is not only a problem in developing
countries but also affects most of the industrialised
countries to a greater or lesser degree. It has currently
been estimated that half of the population lives in areas
in which there is a risk of having disorders due to iodine
deficiency such as what occurs in several European
countries such as Germany, Belgium, Denmark, Spain,
France, Greece, Ireland and Italy. Zones with endemic
goitre or some other alterations related to iodine defi-
ciency have been detected in Spain [17-19].
Until several years ago the fundamental problem of
iodine deficiency lay in endemic goitre but in the last
decades studies have demonstrated a wide spectrum of
disorders caused by iodine deficiency during pregnancy
such as an increase in the number of abortions and
dead foetuses, an increase in neonatal morbimortality
and hearing defects in infants [20], a reduction in intel-
lectual capacity and growth, congenital abnormalities
with permanent neuromotor damage [21,22] as well as
the attention deficit syndrome and hyperactivity [23,24].
According to the WHO, lack of iodine is the most fre-
quent cause of mental retardation and irreversible brain
lesions in the world [4].
Recent studies have demonstrated that iodine intake
during gestation is low, even in areas where theoretically
there are institutional prevention programmes to pro-
mote the consumption of iodised salt [18,25-27]. All
these studies have been determining factors for the
Spanish and the Catalan Societies of Endocrinology and
Nutrition, the Spanish Society of Gynaecology and
Obstetrics and the Ministry of Health and Social Policies
to consider pregnant women as a risk group for disor-
ders as a consequence of iodine deficit and to thereby
recommend a diet rich in iodine and iodised supple-
ments. Iodine deficiency in this population, albeit mod-
erate, represents a high risk of cerebral lesions in the
foetus [19,22].
The contribution of the quantity of iodine necessary
for a good health status has been included as a basic
human right: “All children have the right to an adequate
intake of iodine to ensure normal development”, espe-
cially children yet to be born and thus, “All mothers
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have the right to adequate iodine ingestion during gesta-
tion to ensure that their child achieves an optimum
mental development” [28,29].
Some of the interventions most frequently studied
during gestation have been the cessation of smoking
and the promotion of maternal breastfeeding. McBride
[30] hypothesised that pregnancy may be an “appropri-
ate time for learning” to give up smoking since there is
a greater perception of risk in this period and of perso-
nal results in pregnancy which provoke affective or
strong emotional response and redefines social function
or the self-conception of a woman, especially when fail-
ure in fulfilment of a social function results in social
stigmatisation. This “appropriate time for learning” is
not only appropriate for smoking cessation but also for
any other health habit of the pregnant woman such as,
for example, alimentary habits.
Some studies have demonstrated that the effectiveness
of individual versus group Education for Health is similar
[31-33] in different populational groups (diabetics, infant
asthmatics or pregnant women), while others have
reported favourable results in group interventions [34,35].
The interest in group education has grown in the last
years, although very few studies have formally evaluated
their effectiveness compared with individual education.
In general, group versus individual education carries a
reduction in health care costs in hospitalisations, medi-
cal consultations and the consumption of drugs for
some chronic diseases such as diabetes mellitus and
rheumatic diseases as well as different aspects of mater-
nal-foetal health [36].
However, there are numerous difficulties involved in
the development of group education such as for exam-
ple the inadequate or imprecise definition of the educa-
tional objectives, the difficulties in evaluating the
process and the results as well as the variable attendance
of the patients and the limitations in the material and
human resources available. Nonetheless, there is suffi-
cient evidence to clearly indicate that these interventions
are possible and effective.
The relevance of this study lays not only in knowing the
type of educational intervention (group or individual),
with modification of alimentary habits in pregnant women
being the most effective, but also in performing a follow
up of both hygienic-dietetic habits in the consumption of
iodine rich foods and ioduria during the three trimesters
of gestation. It is particularly of note that in the first trime-
ster, the critical time in embryonic development, midwives
in primary care centres should carry out a health care edu-
cation intervention (individual or group) on these habits
with special emphasis on the consumption of foods with
high iodine content and iodine supplements.
If the results obtained by this study demonstrate
the presence of generalised iodine deficiency during
gestation, new studies would be required in other areas
of Catalonia and the rest of Spain and would support the
need to implement systematic programmes of iodine sup-
plementation during gestation as well as the incorpora-
tion of specific educational programmes on alimentary
habits.
Hypothesis
The hygienic-dietetic habits of a pregnant woman has
repercussion on both the nutritional status of the
mother and the development and growth of the foetus.
According to data obtained in a previous study carried
out within the Primary Care setting of Catalonia, there
is reduced consumption of foods rich in iodine since
71% report eating fish less than three times per week,
18% do not drink milk daily, only 42% use iodised salt
for food condimentation and preparation and 18% of
the pregnant women surveyed continue to smoke during
gestation. We therefore consider that:
1st HYPOTHESIS
Most pregnant women in Catalonia have hygienic-diete-
tic habits which involve reduced intake of foods contain-
ing iodine (such as the eating of fish and the use of
iodised salt for food condimentation) and in addition,
an important percentage of these women continue to
smoke during gestation.
2nd HYPOTHESIS
Most of the pregnant women in Catalonia have ioduria
(levels of iodine in urine) with values of less than
150 μg/L (value considered as iodine deficiency) taking
into account that the elimination of iodine in urine dur-
ing gestation rises due to a physiological increase in glo-
merular filtration.
Objectives
General objective 1
o know the hygieninc-dietetic habits with respect to the
consumption of iodine-rich foods and smoking of
women during the three trimesters of gestation.
General objective 2
To know the prevalence of ioduria less than 150 μg/L
(iodine deficiency) and the factors associated with its
appearance during the first three months of gestation.
Secondary Objectives
1. Validate the questionnaire on nutritional iodine
status in pregnant women.
2. Determine the iodine-rich foods consumed by
pregnant women in each trimester of gestation and
how these foods are prepared (boiled, fried,
baked...).
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3. Determine whether pregnant women use iodised
salt in the preparation and condimentation of foods.
4. Determine whether pregnant women take any
supplement containing iodine during gestation.
5. Describe the modifications in the smoking habits
produced during gestation.
6. Compare the nutritional iodine status of the preg-
nant population between the different Primary Care
Centres (PCC) participating in the study, ethnic
groups, levels of education and gestational trimester.
7. Study the repercussions of the educational inter-
ventions on hygienic-dietetic habits and smoking as
well as on iodurias and the taking of iodine
supplements.
Methods/Design
Design
Cluster randomised, controlled, multicentre trial. Rando-
misation unit: primary care team (PCT).
Setting
46 PCTs from the province of Barcelona that pro-
vide health coverage to urban, semirural and rural
populations.
Study population
All the pregnant women over the age of 17 years attend-
ing consultation to a midwife during the first trimester
of gestation in the different participating PCC during
the study period (2007-2010).
Exclusion criteria
Pregnant women in the second or third trimester of
gestation; pregnant women with diagnosed thyroid dis-
ease; pregnant women without a telephone; pregnant
women with communication difficulties (cognitive or
sensory deterioration, language barrier); pregnant
women who do not consent to participate in the study.
Sample size calculation
The sample size has been calcuated by multipying the
size of a randomized simple design by the design effect.
For the simple randomized design an alpha error of 0.05
and a beta error of 0.20 in a bilateral contrast are con-
sidered, requiring 204 pregnant women in the interven-
tion group and 204 in the non intervention group to
detect a difference greater than or equal to 15% in the
prevalence of iodine deficiency between the two. After
extensive review of the literature on group educational
interventions in a pregnant population, the investigative
team [37-40] considered that the intervention to be
undertaken in the intervention group will achieve an
improvement of at least 15% in hygienic-dietetic habits
and thus in the levels of ioduria. A proportion of iodine
deficiency of 44% in the non intervention group is
assumed as indicated by studies performed in popula-
tions in the Pyrenees and the coast of the Maresme,
areas near the study setting [18]. A loss to follow up of
15% has been estimated. Using an intracluster correla-
tion coefficient of 0.05 [41-43], and based on an average
of 25 pregnant women per PCT, the design effect is 2.2.
Therefore, 898 pregnant women and 36 PCT are
needed.
Data Collection
Dependent Variables: iodine deficiency (yes, no), is
defined as ioduria less than 150 μg/lL
Independent Variables:
Variables related to the woman (information obtained
through a individualized interview):
- Administrative: PCT, midwife, data collection date,
patient code, telephone number.
- Sociodemographic: date of birth, level of education,
etnia.
- Obstetric: n° of pregnancies brought to term; n°
premature births, n° of miscarriges and n° of live
births, trimester of gestation of the woman (1st, 2nd
or 3rd).
- Related to smoking: smoker (no, yes), cigarettes/
day prior to gestation, cigarettes/day during gesta-
tion, ex-smoker because of pregnancy, ex-smoker
and time since cessation of smoking.
- Related to consumption of iodine-rich foods:
▪ Consumption of milk: glasses/day
▪ Consumption of yoghourt: units/week and type
(whole or skimmed).
▪ Consumption of cheese: rations/week and type
(cured, semi-cured and fresh).
▪ Consumption of vegetables: times/week, usual
preparation (raw, fried, grilled/baked, steamed,
boiled) and use of water in which they have been
boiled (yes, no and no answer).
▪ Consumption of vegetables and garden pro-
duce: times/week.
▪ Consumption of fish: times/week, usual pre-
paration (raw, fried, grilled/baked, steamed,
boiled).
▪ Consumption of tinned tuna: times/week.
▪ Consumption of tinned sardines: times/week.
▪ Consumption of meat and derivatives: times/
week.
▪ Consumption of eggs: units/week.
▪ Consumption of fruit: units/week and types
(strawberries, pineapple, peaches, bananas,
oranges and others).
▪ Consumption of nuts: times/week.
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- Consumption of iodised salt: yes (time of con-
sumption), no.
- Consumption of multiple vitamins containing
iodine: yes (type), no.
- Consumption of potassium iodine supplement: yes
(type), no.
- Related to the intervention: study group (interven-
tion, non intervention), attendance to group work-
shop (yes, no).
Variables related to the midwife (information obtained
through a individualised interview): years in the profes-
sion, primary care nursing training, mean number of
visits per day.
Variables related to the PCT (information obtained
through an individualised interview): population
assigned, mean age of population assigned, whether or
not it is a teaching center for residents, number of
midwives.
Description of the Study
The phases of the study are:
* PHASE 1. Recruitment of primary care nurses
(PCN): the project was presented to all the PCN within
the study setting to recruit midwives interested in parti-
cipating. Those who were interested in collaborating
signed a document of commitment to participate in the
study.
* PHASE 2. Creation of the study groups (interven-
tion-IG and non intervention-NIG) and midwife
training programme:
- The randomisation unit was the PCN. Using simple
randomisation the centres distributed the IG and NIG
at a proportion of 1:1.
- The formation of the participating midwives was car-
ried out on 3 centralised work days during which the
develpment of the study was explained in depth and
they were given instructions on correct completion of
the questionnaire on hygienic-dietetic habits in both a
paper and electronic format. Each professional was
assigned a support investigator to clarify any doubts
which may arise during the study period. The objective
of session was for the midwives to obtain sufficient
training to avoid possible variability in the development
of the study and in the collection and registration of
data.
* PHASE 3. Pilot study: this was carried out in three
randomly selected PCN with 30 pregnant women who
were not included in the study in order not to affect the
final results. This pilot study evaluated the study inclu-
sion process of the pregnant women, data collection by
paper and electronic questionnaire as well as the
appointment circuit, referral and presentation of ioduria
results.
* PHASE 4. Recruitment of the pregnant women,
initial evaluation and request for first ioduria (in IG
and NIG):
- Recruitment of the pregnant women: the pregnant
women will be consecutively recruited from the women
attending consultation to the midwife until the number
of 25 women required by each PCN has been reached.
Each midwife will know the number of women that they
must recruit for the study. If a pregnant woman fulfils
the inclusion criteria the midwife will explain the study
to her and will ask for her participation. If the woman
accepts she will be given the study information sheet in
which the objectives and the characteristics are
described and she will be asked to sign the informed
consent form to thereby be included in the study. If the
woman refuses to participate the reasons for this will be
noted, as will the administrative, sociodemographic and
obstetric variables with the aim of determining the pro-
file of this type of pregnant woman.
- Initial evaluation of the pregnant women: on the first
contact with the women and through an individualised
interview the midwife will collect the following variables:
administrative, sociodemographic, obstetric, those
related to smoking, consumption of foods rich in iodine,
iodised salt and iodised multiple vitamins. All the data
will be reported in an electronic data collection file
(EDCF) which will include the rule of internal coherence
to guarantee the quality control of the data. Following
the interview the midwife will make an educational
intervention on the importance of good alimentation
during pregnancy and the repercussions this has on
maternal and foetal health, with special emphasis on the
importance of the consumption of foods rich in iodine
and iodised supplements. An informative sheet will also
be provided on the importance of iodine during
gestation.
- Request for ioduria during the first trimester: the
midwife will request an ioduria test and will explain the
woman how to correctly collect the urine and will pro-
gram the appointment for the second trimester visit of
the pregnancy. On receipt of the ioduria results the
midwife will note these in the EDCF. In cases in which
iodine deficiency is detected the midwife will duly inter-
vene, thus the reason for including the telephone num-
ber of the pregnant woman in the questionnaire. If
iodine supplementation is indicated the administration
will begin on collection of the first urine sample to
avoid underestimation of the prevalence of iodine defi-
ciency in the first trimester. Ioduria will be analysed
using the Benotti&Benotti method performed in the
laboratory of the Hospital Clinic of Barcelona.
* PHASE 5. Group Education Intervention (only in
IG): the coordinating midwives in each zone will be
responsible for performing the educational workshops
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on hygienic-dietetic habits in the pregnant women in
the intervention group. This workshop will be held in
the first trimester since this is when organogenesis is
produced and is therefore the time of greatest risk for
the appearance of alterations in the development of the
foetal central nervous system in cases of maternal iodine
deficiency. The content of the educational workshop
will be the same to avoid a variation in information and
transmission of knowledge to the pregnant women, that
is, to ensure receipt of homogeneous information by the
pregnant women.
* PHASE 6. Follow up (in IG and NIG): if a pregnant
woman does not attend the appointment she will be
called by telephone and if she cannot be contacted after
10 attempts she will be withdrawn from the study. The
interview on hygienic-dietetic habits will be given in the
second and third trimester appointments and determina-
tion fo ioduria will be requested. The reasons for partici-
pant withdrawal will be reported and a flow chart of the
patients will be created throughout the study.
* PHASE 7. Validation of the questionnaire on the
iodine nutritional status in pregnant women: the
questionnaire has been elaborated by the investigator
team after extensive review of the literature and finally
based on the alimentary table according to iodine con-
tent (mcg/100 g) included in the monography on “Los
alimentos y la salud” (Food and Health) (Egura R. Webb
S. Tovar JL. Y Gausí C. Los minerales y la salud. Barce-
lona: Nuevas Ediciones de Bolsillo, S.L.; 2000. p 161-97).
The questionnaire describes the foods with the greatest
iodine content and the quantities consumed, the use of
iodised salt and multiple vitamins containing iodine and
smoking since the latter is a goitrogenic substance.
Neither the origin of the foods nor the place in which
the food is prepared is taken into account because of
the impossibility to evaluate and confirm these aspects,
despite the influence in the quantity of iodine con-
sumed. Validation will be undertaken by an expert in
psychometry from the Autonomous University of Barce-
lona (UAB) taking into account ioduria values.
* PHASE 8. Completion of data collection: after per-
forming the third trimester appointment data collection
will be concluded. The periodic controls of the data
reported in the EDCF will have localised and corrected
any incoherences that may have arisen.
* PHASE 9. Data analysis and diffusion of the
results: the data obtained will be analysed and a final
report will be elaborated with diffusion of the results in
different scientific scenarios.
Statistical analysis
Data will be analysed in concordance with the Consort
Cluster guide [44], and all analyses will be done on an
intention to treat basis. A descriptive analysis and an
analysis of baseline comparability between the study
groups will be performed for the variables studied.
A Student’s t test or a Mann-Whitney U test will be
used to compare means with two categories. An
ANOVA test will be done to compare means with two
or more categories, and a Chi- squared test or a Chi
-squared tendency test will be done to compare catego-
rical variables. A multilevel logistic regression will be
carried out to evaluate the association between the
dependent and the independent variables that were sta-
tistically significant in the bivariate analysis. All analyses
will be adjusted for potential confounding factors and
for variables with clinical relevance. All tests will be
done with a 95% bilateral confidence interval. SPSS 15,
STATA 10 and HLM6 will be used.
Quality Control
Several procedures are employed to ensure the quality
of the study data, thus maximizing the validity and relia-
bility of the program delivery and outcome assessments.
These are:
• Formation of the professionals participating in the
study.
• Use of an electronic data collection system with a
system of warnings and internal coherency norms.
• Regular meetings and mailings between members
of the study group and all participating centres.
Ethical Aspects
In the first contact with the pregnant woman, she will
be given information about the study and will sign an
informed consent form if she wishes to participate. The
informed consent will describe the ethical conditions
and the participant’s right to intimacy, anonymity, confi-
dentiality, withdrawal and information. The investigators
are committed to respecting the norms of good clinical
practice, as well as the requirements of the Helsinki
Declaration. The protocol has been evaluated and
approved by the Ethical Committee of Scientific
Research of the Primary Care Research Institute Jordi
Gol (Barcelona, Spain). Confidentiality of data: Only the
investigators and monitors/auditors of the study will
have access to the data of the subjects who agreed to
participate.
Discussion
One of the strengths of the present study is its design
which is pragmatically oriented with respect to the
needs of time and material resources.
Another strength of the study is the large number of
midwives and patients involved, reinforcing the external
validity of the data.
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Since no register of women in the first trimester of
pregnancy is available, selection of the study population
can not be approached with a simple randomised
sample but will rather be performed by consecutive
sampling which could lead to a selection bias, the self-
selection of the volunteer. To determine the possible
presence of such a bias the administrative, sociodemo-
graphic and obstetric variables of the women who refuse
to participate in the study will be analysed.
To increase the validity and reliability of the data col-
lection of the hygienic-dietetic habits by individualised
interview, the midwives have been especially trained in
this task following a training session prior to initiation
of the pilot study and a support investigator will be
available to solve any doubts which may arise.
The difficulty in determining iodine intake through
diet will be compensated by the determination of iodine
levels in urine which is considered a good marker of
iodine ingestion according to the WHO, UNICEF and
ICCIDD [4,45].
To avoid the phenomenon of contamination which
may appear when the intervention influences the sub-
jects in the control group (frequent when the same
work centre of the professionals belongs to different
study groups), randomisation of the intervention will be
performed by the PCN and not by study subjects.
Although the unit of randomisation is the primary care
unit, the intervention is given at the individual level and
the outcomes are also measured at this level. The esti-
mation of the design effect will be taken into account in
all the main analyses.
Since participant losses and withdrawals randomly
occur, any subject exclusion from the analysis may later
affect group comparability. To preserve this all the
patients included in the study will be evaluated accord-
ing to the intention to treat principle and thus, all the
patients will be analysed as pertaining to the group to
which they were initially assigned independently of the
treatment they have actually received.
Lastly, it should be pointed out that if the question-
naire on the nutritional status of iodine is found to be
valid and reliable, it may be a valuable tool for the
detection of iodine deficiency during gestation in mid-
wife consulting offices without the need to request
ioduria. The midwife may thereby intervene rapidly and
adequately in such a situation informing the woman as
to the role of iodine in foetal development and under-
line the importance of foods rich in iodine.
If the results obtained demonstrate the presence of
iodine deficiency in an important proportion of the
gestating population, this would support the implemen-
tation of preventive interventions to improve and inten-
sify health care education programmes in pregnant
women as well as to make the public health authorities
aware of the importance and repercussions of iodine
deficiency and attempt to systematically implement sup-
plementation of foods containing iodine, a measure
which already prevails in some countries such as
Argentina.
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